The efficacy of combination of chemotherapy and immunotherapy compared with immunotherapy alone for NSCLC

被引：0
|
作者：
Hirano, Satoshi [1 ]
Takahashi, Hidekazu [1 ]
Hiroyuki, Amano [2 ]
Toshiaki, Inazaki [2 ]
Kuroki, Tsuguko [2 ]
Urano, Akira [2 ]
Kure, Fujihiro [2 ]
Fujita, Tetsuo [2 ]
Nakamura, Makoto [2 ]
Nakamura, Sukeyuki [2 ]
机构：
[1] Funabashi Municipal Med Ctr, Dept Med Oncol, Funabashi, Chiba, Japan
[2] Funabashi Municipal Med Ctr, Dept Resp Med, Funabashi, Chiba, Japan
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
10.1016/j.annonc.2022.05.322
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P61-2
引用
收藏
页码：S535 / S535
页数：1
相关论文
共 50 条
  • [1] Frontline immunotherapy for NSCLC: alone or not alone?
    Cesare Gridelli
    Francesca Casaluce
    Nature Reviews Clinical Oncology, 2018, 15 : 593 - 594
  • [2] Association of Gender and Outcomes in Patients With Advanced NSCLC Treated With Immunotherapy Alone or in Combination With Chemotherapy Upfront
    Jimenez, J. Torres
    Gorria, T.
    Auclin, E.
    Castro, N.
    Albarran-Artahona, V.
    Ruffinelli, J. C.
    Pinato, D.
    Routy, B.
    Nana, F. Aboubakar
    Reyes, R.
    Vinolas, N.
    Blanc-Durand, F.
    Lopes, G.
    Nadal, E.
    Arasanz, H.
    Pascal, M.
    Teixido, C.
    Besse, B.
    Reguart, N.
    Mezquita, L.
    Jimenez, J. Torres
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S385 - S386
  • [3] Combination of chemotherapy and immunotherapy may overcome the resistance to immunotherapy alone in pulmonary lymphoepithelial carcinoma
    Hung, Huei-Yang
    Lai, Wei-An
    Chuang, Cheng-Hao
    Yang, Chih-Jen
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2024, 40 (06): : 601 - 602
  • [4] Chemotherapy in combination with immunotherapy
    不详
    BRITISH MEDICAL JOURNAL, 1939, 1939 : 688 - 689
  • [5] Immune-related adverse events in advanced NSCLC treated with immunotherapy alone or concurrent chemotherapy and immunotherapy.
    Melson, John
    Reed, Daniel
    Horton, Bethany J.
    Moore, Margaret
    Brown, Jacqueline Theresa
    Gentzler, Ryan D.
    Hall, Richard Delmar
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [6] LUNG CANCER Frontline immunotherapy for NSCLC: alone or not alone?
    Gridelli, Cesare
    Casaluce, Francesca
    NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (10) : 593 - 594
  • [7] Predictive and prognostic value of Patras Immunotherapy Score (PIOS) in patients with advanced NSCLC treated with immunotherapy/chemotherapy combination
    Dimitrakopoulos, F-I. D.
    Christopoulos, P.
    Elshiaty, M.
    Daniello, L.
    Pyrousis, I.
    Kottorou, A.
    Makatsoris, T.
    Kalofonos, C.
    Koutras, A.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1050 - S1050
  • [8] Combination immunotherapy and antifungal chemotherapy
    Stevens, DA
    CLINICAL INFECTIOUS DISEASES, 1998, 26 (06) : 1266 - 1269
  • [9] Comparative Efficacy and Safety of Immunotherapy Alone and in Combination With Chemotherapy for Advanced Non-small Cell Lung Cancer
    Wang, Xue
    Niu, Xiaomin
    An, Na
    Sun, Yile
    Chen, Zhiwei
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [10] EFFECT OF SURGERY, CHEMOTHERAPY AND IMMUNOTHERAPY, ALONE AND IN COMBINATION ON METASTASES OF 13762 MAMMARY ADENOCARCINOMA
    BOGDEN, AE
    TAYLOR, DJ
    MENNINGE.FF
    ESBER, HJ
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1972, 13 (MAR): : 76 - &
12345